NCT03038594View on ClinicalTrials.gov

Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

November 1, 2015

Primary Completion Date

November 2, 2021

Study Completion Date

November 30, 2021

Conditions
BurnsGrowth Hormone Treatment
Interventions
DRUG

Somatropin

DRUG

0.09% Saline Solution

Trial Locations (1)

77550-1220

University of Texas Medical Branch, Galveston

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

United States Department of Defense

FED

collaborator

Pfizer

INDUSTRY

lead

The University of Texas Medical Branch, Galveston

OTHER